Seeking Alpha

Pharmacist$$$$

Pharmacist$$$$
Send Message
View as an RSS Feed
View Pharmacist$$$$'s Comments BY TICKER:
Latest  |  Highest rated
  • Molycorp Price Deterioration: 8 Competitors Who Should Be Concerned [View article]
    Bob doesnt have a positive comment on any company ever or even constructive for that manner
    Feb 9 03:51 PM | 2 Likes Like |Link to Comment
  • Molycorp: Why A Chinese Takeover Will Never Happen [View article]
    at least those who sold near MCP's peak.- stocks that run like that will eventually fall back to earth. You needed to sell obviously. Look at DDD and WDAY
    Jan 24 05:59 AM | Likes Like |Link to Comment
  • Molycorp: Why A Chinese Takeover Will Never Happen [View article]
    Since the tenor of this article is about Chinese interest in MCP refining techniques etc, what do you think would happen if there was a public offer made for MCP by some chinese firms? and or do you think this is even possible.
    Jan 22 05:17 AM | Likes Like |Link to Comment
  • 7 Commodity Stocks Moving On News [View article]
    24 million short dec 15
    Jan 3 08:13 PM | Likes Like |Link to Comment
  • BOOM! Goes The Molycorp: Avoiding 'Manic' Stocks [View article]
    waste my time
    Dec 24 10:18 PM | 2 Likes Like |Link to Comment
  • A 'Rare' Opportunity [View article]
    This article and author seems like mindless stock pumping.
    Dec 22 12:22 AM | 5 Likes Like |Link to Comment
  • Rare Earths Get Run Over [View article]
    ^This
    Nov 15 06:53 PM | Likes Like |Link to Comment
  • Good And Bad News For Molycorp [View article]
    I question your assesment of Molycorp competition besides Lynas. REE AVL etc are just digging holes right now, they are going to need to raise gobs of capital and are years away from producing anything at all. With the Environmental concerns being raised in China, the ability of the Communist government to change quotas on a whim, the increasing tension over the Senkaku islands, the lack of refinement facilities throughout the world, the predictions for increasing demands. Your article fails to mention any of these factors. Would you share thoughts about these items?
    Oct 12 10:47 PM | 7 Likes Like |Link to Comment
  • 3 Reasons Why Molycorp Will Not Be Acquired [View article]
    lol
    Oct 4 05:04 AM | Likes Like |Link to Comment
  • 3 Reasons Why Molycorp Will Not Be Acquired [View article]
    Im guessing we are going to get some announcement about production and/or project goals prior to the earning announcement. Also the China / Japan situation is really not getting any coverage here in the US news. Anyone watch Asia news souces have any links that are current??

    thanks
    Oct 2 10:17 PM | Likes Like |Link to Comment
  • 3 Reasons Why Molycorp Will Not Be Acquired [View article]
    I believe the upside outweighs the downside risk, the cnet article is interesting besides the apple bias, chinas enviromental issues are real and mcp is going to enter full production
    Sep 28 08:45 PM | Likes Like |Link to Comment
  • Why Light Rare Earth Metals Prices Have Furthest to Fall (Part II) [View article]
    No address for all of mcp top management buying stock, no mention of mcp being the only miner, refiner, producer of end product from neo materials. No mention of MCP going to be the only producer in the near future, avl, ree are so far from anything. Why even write this article
    Sep 21 05:02 PM | 3 Likes Like |Link to Comment
  • Arena Takedown - Is It Fair? [View article]
    The germans bombed pearl harbor, thats odd
    Sep 12 09:58 AM | Likes Like |Link to Comment
  • Arena Pharmaceuticals Price Target Sets Low Bar [View article]
    I just lol after all this happened yesterday, for no other reason than orex would get pumped over and over i have bought in everytime it gets low and sold
    Sep 7 04:47 PM | Likes Like |Link to Comment
  • Shares of Orexigen (OREX +16.7%) are soaring after Credit Suisse initiates coverage with an Outperform, saying it likes the prospects of a trial that will look at the cardiovascular impact of Contrave. Leerink Swann also recommends investors buy it aggressively. Meanwhile, it starts Arena Pharmaceutical (ARNA -4.6%) with an Underperform , saying Belviq may not generate enough revenue to justify the stock's current valuation. [View news story]
    I laughed when i read the report this morning
    Sep 6 07:04 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
35 Comments
36 Likes